MARZULLO, Paolo
 Distribuzione geografica
Continente #
EU - Europa 3.960
NA - Nord America 3.433
AS - Asia 797
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 6
AF - Africa 2
Totale 8.213
Nazione #
US - Stati Uniti d'America 3.413
IE - Irlanda 1.449
SE - Svezia 693
DE - Germania 547
UA - Ucraina 474
IT - Italia 431
CN - Cina 311
FI - Finlandia 252
HK - Hong Kong 179
IN - India 138
VN - Vietnam 112
GB - Regno Unito 45
IR - Iran 44
FR - Francia 32
BE - Belgio 21
CA - Canada 20
EU - Europa 15
TR - Turchia 7
RU - Federazione Russa 4
RO - Romania 3
BR - Brasile 2
CL - Cile 2
CZ - Repubblica Ceca 2
ES - Italia 2
JP - Giappone 2
NL - Olanda 2
PH - Filippine 2
AM - Armenia 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
MK - Macedonia 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.213
Città #
Dublin 1.444
Jacksonville 911
Dearborn 415
Chandler 292
Wilmington 234
Lawrence 180
Princeton 180
Hong Kong 179
San Mateo 139
Beijing 117
Dong Ket 112
Ann Arbor 87
Andover 85
Ashburn 85
Piemonte 81
Bremen 55
Boardman 41
Milan 33
Philadelphia 32
Woodbridge 30
Houston 26
Norwalk 26
Hefei 25
Nanjing 25
Kunming 24
Brussels 21
Zanjan 21
Fairfield 18
Novara 17
Helsinki 16
Monmouth Junction 15
Rome 15
Guangzhou 14
Turin 14
Nanchang 13
Jinan 12
Toronto 12
Alessandria 11
Ardabil 8
Shenyang 8
Casalecchio Di Reno 7
Düsseldorf 7
Berlin 6
Bologna 6
Borgo Vercelli 6
Napoli 6
Paris 6
Seattle 6
Torino 6
Xian 6
Zhengzhou 6
Augusta 5
Chengdu 5
Hebei 5
Kocaeli 5
Leawood 5
Naples 5
Nardò 5
Winnipeg 5
Palermo 4
Pescantina 4
West Jordan 4
Baotou 3
Cambridge 3
Cassano Magnago 3
Cuggiono 3
Dallas 3
Grafing 3
Pioltello 3
Rocca San Felice 3
San Diego 3
Vercelli 3
Wenzhou 3
Wuhan 3
Afragola 2
Appiano Gentile 2
Bagnoli del Trigno 2
Belmont 2
Berbenno Di Valtellina 2
Biella 2
Brno 2
Bulandshahr 2
Busalla 2
Changsha 2
Colturano 2
Des Moines 2
Desenzano del Garda 2
Fuzhou 2
Galliate 2
Giugliano In Campania 2
Gunzenhausen 2
Hangzhou 2
Henderson 2
Jersey City 2
Jiaxing 2
Jinhua 2
Kish 2
Kollam 2
Meda 2
Mülheim 2
Totale 5.281
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 137
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 94
Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy 82
Prediction of Efficacy of Octreotide Therapy in Patients with Acromegaly 81
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 76
Cholecalciferol (vitamin D3) has a direct protective activity against interleukin 6-induced atrophy in C2C12 myotubes 75
Reversibility of joint thickening in acromegalic patients: an ultrasonography study 72
Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin 71
Cardiovascular aspects in acromegaly: effects of treatment 70
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure 69
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 68
Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life 67
Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS) 66
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins 65
Thyroid cancer phenotypes in relation to inflammation and autoimmunity 64
Transsphenoidal surgery for pituitary adenomas: early results from a single center 64
CV 205-502 treatment in therapy-resistant acromegalic patients 63
Acute and chronic effects of octreotide on thyroid axis in GH-secreting and clinically nonfuctioning pituitary adenomas 63
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison to patients without Cushing's disease. 63
Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study 63
Effect of octreotide pretreatment on surgical outcome in acromegaly 63
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 63
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 62
Cardiac effect of thyrotoxicosis in acromegaly 61
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly 61
Long-term effect of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly 61
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 61
Muscle sympathetic nerve activity in patients with acromegaly 59
Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome 59
One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study. 58
Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg) 58
Embolization for Insulinoma in Complicated Severe Obesity: Description of an Inoperable Case and Review of the Literature 58
Clinical picture and the treatment of TBI-induced hypopituitarism 57
Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy 57
Comment on prostatic hyperplasia in patients with acromegaly 57
Percutaneous ethanol injection under Power Doppler ultrasound assistance in the treatment of autonomously functioning thyroid nodules 56
Altered multisensory temporal integration in obesity 56
[Preliminary data on the effectiveness of resveratrol in a new formulation in treatment of hot flushes] 56
Comparison among different dopamine-agonists of new formulation in clinical management of macroprolactinomas 55
Early vascular alterations in acromegaly 55
Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients 55
The impact of the metabolic phenotype on thyroid function in obesity 54
Plasma Oxytocin Concentration in Pre- and Postmenopausal Women: Its Relationship with Obesity, Body Composition and Metabolic Variables 54
Analysis of Predictive Equations for Estimating Resting Energy Expenditure in a Large Cohort of Morbidly Obese Patients 54
Acylated ghrelin decreases during acute exercise in the lean and obese state 53
Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity 53
The pathophysiology of abdominal adipose tissue depots in health and disease 53
Mechanisms in endocrinology: The crosstalk between thyroid gland and adipose tissue: Signal integration in health and disease 53
Acromegaly and prostate cancer 53
Impaired luteinizing hormone responsiveness to gonadotropin-releasing hormone in the inferior petrosal sinuses of hyperprolactinemic patients 53
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 52
Prostatic hyperplasia: an unknown feature of acromegaly 52
Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing GH excess and deficiency in adults 52
Effects of one-year treatment with octreotide on cardiac performance in patients with acromegaly 52
Assessment of fat-free mass from bioelectrical impedance analysis in men and women with Prader-Willi syndrome: cross-sectional study 52
Circulating adipokines and metabolic setting in differentiated thyroid cancer 52
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 52
New medical approaches in pituitary adenomas 50
Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome 50
Metabolic alterations in patients who develop Traumatic Brain Injury (TBI)-induced hypopituitarism. 50
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome 50
Vitamin D and neurological diseases: An endocrine view 50
The lullaby of the sun: the role of vitamin D in sleep disturbance 50
Vitamin D as a Biomarker of Ill Health among the Over-50s: A Systematic Review of Cohort Studies. 50
Preface 49
Acromegaly and immune function 49
Non-surgical ablative therapies for inoperable benign insulinoma 49
Is Caloric Restriction Associated with Better Healthy Aging Outcomes? A Systematic Review and Meta-Analysis of Randomized Controlled Trials 49
Effect of growth hormone on cardiac function 48
Increased arterial intima media thickness by M-B-mode echoDoppler ultrasonography in acromegaly 48
Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals 48
Aging and comorbidities influence the risk of hospitalization and mortality in diabetic patients experiencing severe hypoglycemia 48
Lymphocytes and immunoglobulin patterns across the threshold of severe obesity 47
Levothyroxine Replacement in Obese Adults: The Role of Metabolic Variables and Aging on Thyroid Testing Abnormalities 47
Acromegalic axial arthropathy: a clinical case-control studY 47
Is growth hormone bad for your heart: Cardiovascular impact of GH deficiency and excess 46
Lack of association between the tetranucleotide repeat polymorphism in the 3'-flanking region of the leptin gene and hypertension in severely obese patients 46
Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. 46
Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations 46
Malattie ipotalamo-ipofisarie 45
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. 45
Obesity modifies expression profiles of metabolic markers in superficial and deep subcutaneous abdominal adipose tissue depots 45
Diagnosis and treatment of GH deficiency in Prader–Willi syndrome 45
The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure 45
Dynamics of GH secretion during incremental exercise in obesity, before and after a short period of training at different work-loads 45
null 45
Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome 45
Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients 44
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 44
Growth hormone deficiency in treated acromegaly 44
Immunomodulatory effects of vitamin d in thyroid diseases 44
Abdominal fat index by ultrasound does not estimate the metabolic risk factors of cardiovascular disease better than waist circumference in severe obesity. 43
Deep Subcutaneous Adipose Tissue: A Distinct Abdominal Adipose Depot 43
Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome 43
Growth hormone deficiency in children 43
CV 205-502 in the treatment of tumoral and non-tumoral hyperprolactinemic states 43
Methimazole Treatment and Risk of Acute Pancreatitis: A Population-based Cohort Study 43
Insights into non-classic and emerging causes of hypopituitarism 43
Effect of Different Dopaminergic Agents in the Treatment of Acromegaly 42
Growth hormone disorders in adults 42
Totale 5.529
Categoria #
all - tutte 41.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 0 6 18
2019/20201.658 6 7 151 9 257 255 371 84 180 174 160 4
2020/20211.301 151 1 171 3 176 60 177 8 190 27 193 144
2021/20221.281 43 27 214 137 60 26 108 40 105 31 216 274
2022/20232.752 199 108 178 66 194 200 71 135 1.438 11 90 62
2023/2024637 69 80 53 18 150 16 192 25 18 8 8 0
Totale 8.399